In addition, estrogen E2 enhances the expression of NRF2-dependent antioxidant genes in normal, malignant BRCA1-deficient cells as well as MCF-7 breast cancer cells, via the PI3K/ glycogen synthase kinase 3 beta (GSK3β) pathway [152]. Here, NFE2L2 is linked to breast carcinoma.